Anti-Cancer Agent, Herceptin® Filed for Additional Indication, and Dosage and Administration By "New Drug Application Based on Evidence in the Public Domain"
May 09, 2011
Anti-Cancer Agent, Herceptin® Filed for Additional Indication, and Dosage and Administration By "New Drug Application Based on Evidence in the Public Domain"
Anti-Cancer Agent, Herceptin® Filed for Additional Indication, and Dosage and Administration By "New Drug Application Based on Evidence in the Public Domain"
